HIGHLIGHTS   |  May 21, 2020   DETECT-A Blood Test Combined with PET-CT May Lead to Surgery with Intent to Cure In this study, the feasibility and safety of DETECT-A coupled with PET-CT imaging to detect cancer was evaluated using a prospective, interventional study of 10,006 women not previously known to have cancer. Read more ADVERTISEMENT   FDA Approves Expanded Olaparib Indication to Include Combination with Bevacizumab The FDA expanded the indication of olaparib to include a combination regimen with bevacizumab for the first-line maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer. Read more ADVERTISEMENT Proven portfolio of tests + services, that’s our Foundation. Our portfolio of genomic tests & services is designed for cancer patients at any line of therapy, with proven utility for clinical decision making. Rx only; advanced cancer; doesn’t guarantee treatment match. Learn more     In Case You Missed It

Strategies Combining Nivolumab Show Promise for Classic Hodgkin Lymphoma Researchers found that 2 studied strategies, which combined nivolumab and doxorubicin, vinblastine, and dacarbazine, are feasible, highly effective, and result in excellent 12-month progression-free survival. Read more